Skip to content
10-K

Annual Report

NEVRO CORP.

0000950170-24-019464

← back to feed
Filed
Feb 23, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Feb 14, 2024 36.4M sh
Long Term Debt FY 2023 · Dec 31, 2022 $186.87M
Current Liabilities FY 2023 · Dec 31, 2022 $79.21M
Total Liabilities FY 2023 · Dec 31, 2022 $278.53M
Current Assets FY 2023 · Dec 31, 2022 $562.94M
Total Assets FY 2023 · Dec 31, 2022 $602.41M
Shares Diluted FY 2023 · Dec 31, 2021 34.82M sh
Capex FY 2023 · Dec 31, 2021 $12.34M
Operating Cash Flow FY 2023 · Dec 31, 2021 −$41.88M
Eps Diluted FY 2023 · Dec 31, 2021 −$3.77
Eps Basic FY 2023 · Dec 31, 2021 −$3.77
Sga Expense FY 2023 · Dec 31, 2021 $309.31M
Rd Expense FY 2023 · Dec 31, 2021 $47.67M
Net Income FY 2023 · Dec 31, 2021 −$131.36M
Operating Income FY 2023 · Dec 31, 2021 −$110.93M
Gross Profit FY 2023 · Dec 31, 2021 $266.04M
Revenue FY 2023 · Dec 31, 2021 $386.91M
Stockholders Equity FY 2023 · Dec 31, 2020 $388.46M